Roland Wandeler

Corporate Officer/Principal en GRIFOLS, S.A. .

53 años

Health Technology

Consumer Services

Perfil

Roland Wandeler is President-Biopharma Business Unit at Grifols SA since 2024.
Former roles include Chief Executive Officer at Sundance Biosciences, Inc. from 2022 to 2023, VP, GM-US Bone Health & Cardiology Business Unit at Amgen, Inc., and Chief Operating Officer at MorphoSys AG from 2020 to 2021.
Education includes graduate and doctorate degrees from the Swiss Federal Institute of Technology.

Cargos activos de Roland Wandeler

Empresas	Cargo	Inicio
GRIFOLS, S.A.	Corporate Officer/Principal	01/01/2024

Todos los cargos activos de Roland Wandeler

Antiguos cargos conocidos de Roland Wandeler.

Empresas	Cargo	Fin
Encinal Bio, Inc.	Director Ejecutivo	01/10/2023
MORPHOSYS AG	Director de Operaciones	31/12/2021
AMGEN INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Roland Wandeler.

Formación de Roland Wandeler.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Roland Wandeler.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Grifols SA Grifols SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals, diagnostic and bio supplies	Health Technology
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Encinal Bio, Inc.